C12N2770/36151 - CPC Classification Index

ClassID:

111682 ⎘

C12N2770/36151 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Togaviridae; Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki Methods of production or purification of viral material

Sub-classes:

C12N2770/36152 » relating to complementing cells and packaging systems for producing virus or viral particles 22

Recent Application in this class:

20250326801

2025-10-23

VIRUS-LIKE PARTICLES AND METHODS OF USE

20250213671

2025-07-03

NOVEL RNA AND DNA TECHNOLOGY FOR VACCINATION AGAINST ALPHAVIRUSES AND OTHER EMERGING AND EPIDEMIC VIRUSES

20250146038

2025-05-08

METHODS FOR GENERATING FUNCTIONAL SELF-REPLICATING RNA MOLECULES

20240398921

2024-12-05

VERSATILE VIRUS-LIKE-VESICLES (VLV) PLATFORM FOR INFECTIOUS DISEASES AND CANCER IMMUNOTHERAPY APPLICATIONS

20240067934

2024-02-29

MODULAR VIRAL GENOMES AND METHODS OF PRODUCING THE SAME

20230295242

2023-09-21

Virus-like particles and methods of use

20210388034

2021-12-16

Virus-like particles and methods of use

20200108136

2020-04-09

Methods and compositions for live attenuated viruses

20190153041

2019-05-23

Virus-like particles and methods of use

#10

20190055526

2019-02-21

Retrovirus packaging cell

#11

20180371494

2018-12-27

T7 alpha viral vector system

#12

20170159097

2017-06-08

CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES

#13

20170100474

2017-04-13

Methods and compositions for live attenuated viruses

#14

20170073377

2017-03-16

Virus-like particles and methods of use

#15

20170051307

2017-02-23

Evolution of high-titer virus-like vesicles for vaccine applications

#16

20160375121

2016-12-29

Engineered vesicles comprising antigenic peptides and the uses thereof as modulators of immune responses

#17

20160074500

2016-03-17

Infectious DNA vaccines against chikungunya virus

#18

20160040124

2016-02-11

Adapted lepidopteran insect cells for the production of recombinant proteins

#19

20150226748

2015-08-13

Multiprotein assemblies

#20

20140242114

2014-08-28

cDNA construct of Salmonidae alphavirus

#21

20140170186

2014-06-19

Virus-like particles and methods of use

#22

20140079734

2014-03-20

Methods and compositions for alphavirus replicons

#23

20130337007

2013-12-19

Salmonid alphavirus protein E2

#24

20130053267

2013-02-28

CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES

#25

20130052225

2013-02-28

Infectious DNA vaccines against chikungunya virus

#26

20130022631

2013-01-24

Vaccine for chikungunya virus infection

#27

20120301904

2012-11-29

MULTIPROTEIN ASSEMBLIES

#28

20120231526

2012-09-13

Method for the Purification of Alphavirus Replicon Particles

#29

20110182941

2011-07-28

Alphavirus and alphavirus replicon particle formulations and methods

#30

20110064767

2011-03-17

CDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS

#31

20100239606

2010-09-23

Two-Step Temperature Profile for the Propagation of Viruses

#32

20100055128

2010-03-04

METHOD FOR THE PURIFICATION OF ALPHAVIRUS REPLICON PARTICLES

#33

20090047255

2009-02-19

Alphavirus and Alphavirus Replicon Particle Formulations and Methods

#34

20080317777

2008-12-25

cDNA construct of salmonidae alphavirus

#35

20080286307

2008-11-20

Two-step temperature profile for the propagation of viruses

#36

20080248551

2008-10-09

Methods and compositions for live attenuated viruses

#37

20070172930

2007-07-26

process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof

#38

20070141617

2007-06-21

Enveloped virus vaccine and method for production

#39

20050221493

2005-10-06

Recombinant virus production for the manufacturing of vaccines

#40

20050123555

2005-06-09

Alphavirus vectors and virosomes with modified HIV genes for use as vaccines

#41

20050112752

2005-05-26

Method for the purification of alphavirus replicon particles